Skip to main content
. 2013 May 6;5(2):511–518. doi: 10.3390/cancers5020511

Table 3.

Univariate analysis of risk factors.

Patient characteristics RP (n = 7) NRP (n = 29) p-value
Median age, years 70 67 0.128
Median weight (kilograms) 89.8 90 0.890
Median Gleason score 7 8 0.190
Median Primary Gleason grade 4 4 0.742
Analgesic use (%) 42.8 34.5 0.690
Previous cancer therapy (%)
Antiandrogen 100 93.1 1.000
Second line anti-hormone agent 85.7 48.2 0.104
Chemotherapy 28.6 31 1.000
Docetaxel 14.2 17.2 1.000
Median serum PSA* (ng/mL) 20.9 5.8 0.122

RP = rapid progression; NRP = non-rapid progression; PSA = prostate-specific antigen *.